Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 4.08
(-1.69%)
CNY 4.08
(-1.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.07 Billion CNY | 0.12% |
| 2022 | 1.07 Billion CNY | 19.36% |
| 2021 | 902.95 Million CNY | -23.8% |
| 2020 | 1.18 Billion CNY | -11.69% |
| 2019 | 1.34 Billion CNY | -11.15% |
| 2018 | 1.51 Billion CNY | -9.03% |
| 2017 | 1.65 Billion CNY | 8.88% |
| 2016 | 1.52 Billion CNY | 44.84% |
| 2015 | 1.05 Billion CNY | 38.4% |
| 2014 | 760.52 Million CNY | 88.94% |
| 2013 | 402.52 Million CNY | 33.51% |
| 2012 | 301.5 Million CNY | 20.65% |
| 2011 | 249.9 Million CNY | -16.87% |
| 2010 | 300.6 Million CNY | 15.53% |
| 2009 | 260.2 Million CNY | 1.74% |
| 2008 | 255.75 Million CNY | -17.9% |
| 2007 | 311.52 Million CNY | -12.9% |
| 2006 | 357.65 Million CNY | 11.19% |
| 2005 | 321.65 Million CNY | 87.39% |
| 2004 | 171.65 Million CNY | -2.83% |
| 2003 | 176.65 Million CNY | 79.98% |
| 2002 | 98.15 Million CNY | 8.87% |
| 2001 | 90.15 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.04 Billion CNY | 6.22% |
| 2024 Q3 | 571.62 Million CNY | -42.99% |
| 2024 Q1 | 984.09 Million CNY | -8.8% |
| 2023 Q1 | 1.17 Billion CNY | 9.42% |
| 2023 Q3 | 979.65 Million CNY | -12.36% |
| 2023 Q4 | 1.07 Billion CNY | 10.15% |
| 2023 FY | 1.07 Billion CNY | 0.12% |
| 2023 Q2 | 1.11 Billion CNY | -5.22% |
| 2022 Q2 | 1.39 Billion CNY | 36.72% |
| 2022 Q3 | 1.36 Billion CNY | -2.17% |
| 2022 Q4 | 1.07 Billion CNY | -21.11% |
| 2022 FY | 1.07 Billion CNY | 19.36% |
| 2022 Q1 | 1.02 Billion CNY | 13.11% |
| 2021 Q4 | 902.95 Million CNY | -21.02% |
| 2021 Q3 | 1.14 Billion CNY | 1.48% |
| 2021 FY | 902.95 Million CNY | -23.8% |
| 2021 Q2 | 1.12 Billion CNY | -4.07% |
| 2021 Q1 | 1.17 Billion CNY | -0.89% |
| 2020 FY | 1.18 Billion CNY | -11.69% |
| 2020 Q1 | 1.35 Billion CNY | 0.87% |
| 2020 Q2 | 1.44 Billion CNY | 6.66% |
| 2020 Q3 | 1.63 Billion CNY | 13.39% |
| 2020 Q4 | 1.18 Billion CNY | -27.61% |
| 2019 Q3 | 1.16 Billion CNY | -5.94% |
| 2019 Q2 | 1.23 Billion CNY | -8.89% |
| 2019 Q1 | 1.35 Billion CNY | -10.09% |
| 2019 FY | 1.34 Billion CNY | -11.15% |
| 2019 Q4 | 1.34 Billion CNY | 15.32% |
| 2018 Q3 | 1.77 Billion CNY | -0.59% |
| 2018 FY | 1.51 Billion CNY | -9.03% |
| 2018 Q4 | 1.51 Billion CNY | -14.98% |
| 2018 Q2 | 1.78 Billion CNY | 0.61% |
| 2018 Q1 | 1.77 Billion CNY | 6.98% |
| 2017 FY | 1.65 Billion CNY | 8.88% |
| 2017 Q1 | 1.57 Billion CNY | 3.27% |
| 2017 Q2 | 1.21 Billion CNY | -22.52% |
| 2017 Q3 | 1.43 Billion CNY | 17.47% |
| 2017 Q4 | 1.65 Billion CNY | 15.84% |
| 2016 Q3 | 1.36 Billion CNY | 37.94% |
| 2016 FY | 1.52 Billion CNY | 44.84% |
| 2016 Q1 | 1.1 Billion CNY | 4.75% |
| 2016 Q2 | 992.15 Million CNY | -10.01% |
| 2016 Q4 | 1.52 Billion CNY | 11.4% |
| 2015 Q4 | 1.05 Billion CNY | -0.95% |
| 2015 Q2 | 960.52 Million CNY | 31.48% |
| 2015 Q1 | 730.52 Million CNY | -3.94% |
| 2015 FY | 1.05 Billion CNY | 38.4% |
| 2015 Q3 | 1.06 Billion CNY | 10.63% |
| 2014 FY | 760.52 Million CNY | 88.94% |
| 2014 Q3 | 756.52 Million CNY | 14.27% |
| 2014 Q4 | 760.52 Million CNY | 0.53% |
| 2014 Q2 | 662.02 Million CNY | 40.1% |
| 2014 Q1 | 472.52 Million CNY | 17.39% |
| 2013 FY | 402.52 Million CNY | 33.51% |
| 2013 Q4 | 402.52 Million CNY | 4.8% |
| 2013 Q1 | 296.5 Million CNY | -1.66% |
| 2013 Q2 | 298.5 Million CNY | 0.67% |
| 2013 Q3 | 384.07 Million CNY | 28.67% |
| 2012 Q4 | 301.5 Million CNY | 17.98% |
| 2012 Q2 | 275.5 Million CNY | 0.27% |
| 2012 Q1 | 274.75 Million CNY | 9.94% |
| 2012 FY | 301.5 Million CNY | 20.65% |
| 2012 Q3 | 255.55 Million CNY | -7.24% |
| 2011 FY | 249.9 Million CNY | -16.87% |
| 2011 Q4 | 249.9 Million CNY | 1.11% |
| 2011 Q3 | 247.15 Million CNY | -17.7% |
| 2011 Q2 | 300.3 Million CNY | -0.05% |
| 2011 Q1 | 300.45 Million CNY | -0.05% |
| 2010 FY | 300.6 Million CNY | 15.53% |
| 2010 Q1 | 290.05 Million CNY | 11.47% |
| 2010 Q2 | 346.5 Million CNY | 19.46% |
| 2010 Q3 | 297.75 Million CNY | -14.07% |
| 2010 Q4 | 300.6 Million CNY | 0.96% |
| 2009 Q2 | 225.55 Million CNY | -6.27% |
| 2009 Q4 | 260.2 Million CNY | -11.9% |
| 2009 Q3 | 295.35 Million CNY | 30.95% |
| 2009 Q1 | 240.65 Million CNY | -5.9% |
| 2009 FY | 260.2 Million CNY | 1.74% |
| 2008 Q4 | 255.75 Million CNY | -8.92% |
| 2008 FY | 255.75 Million CNY | -17.9% |
| 2008 Q1 | 292.81 Million CNY | -6.01% |
| 2008 Q2 | 281.8 Million CNY | -3.76% |
| 2008 Q3 | 280.8 Million CNY | -0.35% |
| 2007 Q3 | 304.95 Million CNY | -24.72% |
| 2007 Q1 | 400.89 Million CNY | 12.09% |
| 2007 FY | 311.52 Million CNY | -12.9% |
| 2007 Q2 | 405.1 Million CNY | 1.05% |
| 2007 Q4 | 311.52 Million CNY | 2.16% |
| 2006 Q2 | 271.65 Million CNY | -15.54% |
| 2006 Q1 | 321.65 Million CNY | 0.0% |
| 2006 Q4 | 357.65 Million CNY | -4.28% |
| 2006 FY | 357.65 Million CNY | 11.19% |
| 2006 Q3 | 373.65 Million CNY | 37.55% |
| 2005 Q3 | 251.65 Million CNY | 0.0% |
| 2005 Q4 | 321.65 Million CNY | 27.82% |
| 2005 Q1 | 171.65 Million CNY | 0.0% |
| 2005 FY | 321.65 Million CNY | 87.39% |
| 2005 Q2 | 251.65 Million CNY | 46.61% |
| 2004 Q4 | 171.65 Million CNY | -6.02% |
| 2004 Q2 | 200.95 Million CNY | -14.0% |
| 2004 FY | 171.65 Million CNY | -2.83% |
| 2004 Q1 | 233.65 Million CNY | 32.27% |
| 2004 Q3 | 182.65 Million CNY | -9.11% |
| 2003 Q4 | 176.65 Million CNY | 0.0% |
| 2003 FY | 176.65 Million CNY | 79.98% |
| 2002 FY | 98.15 Million CNY | 8.87% |
| 2001 FY | 90.15 Million CNY | 0.0% |